Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively (Q73595223)
Jump to navigation
Jump to search
scientific article published on 01 April 2000
Language | Label | Description | Also known as |
---|---|---|---|
English | Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively |
scientific article published on 01 April 2000 |
Statements
Serum predominantly activates MAPK and akt kinases in EGFR- and ErbB2-over-expressing cells, respectively (English)
A M Tari
G Lopez-Berestein